Live feed
Filing
SC 13G/A
SC 13G/A0000902219-16-001068·TETRAPHASE PHARMACEUTICALS INC
Schedule 13G ownership disclosure
TETRAPHASE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 88165N105
Event date: 2015-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,012,815
- Percent of class
- 13.7200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-16-001068
- Form type
- SC 13G/A
- Filer
- TETRAPHASE PHARMACEUTICALS INC
- CIK
- CIK 1373707
- Filed
- Feb 11, 2016
- Reporting period
- Dec 31, 2015
- Description
- Schedule 13G beneficial ownership